Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Other Accumulated Expenses (2022 - 2023)

Day One Biopharmaceuticals (DAWN) has disclosed Other Accumulated Expenses for 1 consecutive years, with $179000.0 as the latest value for Q4 2022.

  • On a quarterly basis, Other Accumulated Expenses changed N/A to $179000.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $179000.0, a N/A change, with the full-year FY2022 number at $179000.0, changed N/A from a year prior.
  • Other Accumulated Expenses was $179000.0 for Q4 2022 at Day One Biopharmaceuticals.
  • In the past five years, Other Accumulated Expenses ranged from a high of $179000.0 in Q4 2022 to a low of $179000.0 in Q4 2022.